|
|
Article: LifeSpan BioSciences Enters into Agreement with Roche for Expanded DrugTarget(TM) Localization Database.
- Article from:
- Business Wire
- Article date:
- January 30, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEATTLE -- LifeSpan BioSciences, Inc., a leading antibody company specializing in immunohistochemistry and antibodies to drug target proteins, today announced a multi-year agreement with Roche for a subscription to LifeSpan's DrugTarget Database(TM).
Under the terms of the agreement, Roche Pharma will gain access to all the features of the CNS subset of the DrugTarget Database(TM). These include informatics on more than 3,400 genes, 886 comprehensive immunohistochemistry (IHC) reports with localization information on more than 450 potential drug targets selected by pharmaceutical company subscribers, and innovative search and analysis tools. LifeSpan continues to ...
Related newspaper, magazine, and journal articles:
|
|
Article: LifeSpan BioSciences Multimillion-Dollar Financing, ...
PR Newswire;
March 31, 1997 ;
700+ words
... ... SEATTLE, March 31 /PRNewswire/ -- LifeSpan BioSciences, Inc., an early-stage genomics ... experience in molecular biology. LifeSpan BioSciences, Inc., based in Seattle, Wash ... targets for drug discovery. SOURCE LifeSpan BioSciences Inc. -0- 03/31/97 /CONTACT ...
|
|